Researchers explored data from nearly 800 patients, focusing on a wide variety of outcomes.

Devi Nair, MD, spoke to Cardiovascular Business about her own experience using concomitant LAA occlusion as an add-on to catheter ablation procedures.

This is a Class I recall, according to the FDA. Care teams may need to send in their equipment so that specific hardware updates can be performed.